Autopsy report · NCT06112080

Wearable Auscultation Device Validation in Children

“The Principal Investigator is departing from the study site.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 11 months before it stopped.
• 36 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Strados Labs, Inc.

Sponsor type

Industry

Conditions

Asthma; Asthma in Children; Wheezing; Pediatric Asthma

Interventions

RESP™ Biosensor

Participants

36

Sites

1

Countries

United States

Trials that died the same way

• Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain
  “Principal investigator is leaving the university.” (87% match in meaning)
• Zonisamide in the Treatment of Essential Tremor
  “Principal Investigator left the study site on December 28, 2012.” (84% match in meaning)
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
  “Principal Investigator's departure” (83% match in meaning)
• Assessment of Emotional Memory During Transient Global Amnesia
  “Departure of the principal investigator” (83% match in meaning)
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  “Principal Investigator has left the institution” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.